Danaher Corporation $DHR Shares Acquired by Callan Family Office LLC

Callan Family Office LLC grew its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 102.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 18,899 shares of the conglomerate's stock after acquiring an additional 9,583 shares during the quarter. Callan Family Office LLC's holdings in Danaher were worth $3,733,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. GHP Investment Advisors Inc. lifted its holdings in shares of Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares during the period. Sierra Ocean LLC lifted its holdings in shares of Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares during the period. Red Tortoise LLC lifted its holdings in shares of Danaher by 175.0% during the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate's stock worth $30,000 after purchasing an additional 98 shares during the period. Smallwood Wealth Investment Management LLC acquired a new stake in shares of Danaher during the first quarter worth about $31,000. Finally, Dunhill Financial LLC lifted its holdings in shares of Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after purchasing an additional 67 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Stock Down 1.0%

Danaher stock opened at $202.53 on Friday. The stock has a market capitalization of $145.02 billion, a PE ratio of 43.09, a price-to-earnings-growth ratio of 2.91 and a beta of 0.77. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.41. The business has a 50 day simple moving average of $200.66 and a 200-day simple moving average of $197.25. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business's revenue was up 3.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher's payout ratio is 27.23%.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of the business's stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 11.10% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of research reports. Barclays reaffirmed an "overweight" rating and set a $225.00 target price (up previously from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Danaher in a report on Wednesday. Bank of America decreased their price target on Danaher from $230.00 to $220.00 and set a "buy" rating for the company in a report on Monday, September 22nd. Redburn Partners set a $220.00 price target on Danaher in a report on Wednesday. Finally, Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Seventeen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $244.60.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.